Bellerophon Therapeutics Inc (BLPH)
0.0551
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Bellerophon Therapeutics 1 Year Total Returns (Daily): -99.28% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 30, 2024 | -99.28% |
April 29, 2024 | -99.28% |
April 26, 2024 | -99.25% |
April 25, 2024 | -99.23% |
April 24, 2024 | -99.37% |
April 23, 2024 | -99.42% |
April 22, 2024 | -99.49% |
April 19, 2024 | -99.45% |
April 18, 2024 | -99.43% |
April 17, 2024 | -99.51% |
April 16, 2024 | -99.50% |
April 15, 2024 | -99.48% |
April 12, 2024 | -99.50% |
April 11, 2024 | -99.57% |
April 10, 2024 | -99.46% |
April 09, 2024 | -99.41% |
April 08, 2024 | -99.48% |
April 05, 2024 | -99.52% |
April 04, 2024 | -99.50% |
April 03, 2024 | -99.39% |
April 02, 2024 | -99.33% |
April 01, 2024 | -99.30% |
March 28, 2024 | -99.24% |
March 27, 2024 | -99.26% |
March 26, 2024 | -99.27% |
Date | Value |
---|---|
March 25, 2024 | -99.24% |
March 22, 2024 | -99.28% |
March 21, 2024 | -99.23% |
March 20, 2024 | -99.31% |
March 19, 2024 | -99.19% |
March 18, 2024 | -99.12% |
March 15, 2024 | -99.22% |
March 14, 2024 | -99.12% |
March 13, 2024 | -99.25% |
March 12, 2024 | -99.23% |
March 11, 2024 | -99.23% |
March 08, 2024 | -99.12% |
March 07, 2024 | -98.90% |
March 06, 2024 | -98.50% |
March 05, 2024 | -97.08% |
March 04, 2024 | -97.15% |
March 01, 2024 | -97.26% |
February 29, 2024 | -97.12% |
February 28, 2024 | -97.03% |
February 27, 2024 | -95.95% |
February 26, 2024 | -95.81% |
February 23, 2024 | -96.17% |
February 22, 2024 | -96.07% |
February 21, 2024 | -96.31% |
February 20, 2024 | -96.83% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.57%
Minimum
Apr 11 2024
1.07K%
Maximum
May 16 2023
-18.81%
Average
-61.30%
Median
Apr 12 2021
1 Year Total Returns (Daily) Benchmarks
Janux Therapeutics Inc | 272.7% |
NovaBay Pharmaceuticals Inc | -92.97% |
Palatin Technologies Inc | -18.42% |
iBio Inc | -92.08% |
Theriva Biologics Inc | -36.11% |